Vimseltinib
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Deciphera Pharmaceuticals, LLC
Overview
Vimseltinib is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Vimseltinib clinical trials
Explore related
Medical disclaimer. This page summarizes research about Vimseltinib for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.